← Back
Data updated: Mar 10, 2026
MEDIWOUND, LTD
GastroenterologyOncology
MEDIWOUND, LTD is a biotechnology company focused on Gastroenterology, Oncology.
2022
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 91%
0 drugs Phase 3: 1 Phase 2: 3
Oncology 9%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-12-28
- Latest
- 2024-08-15
- Applications
- 1